US Representative

Scott Franklin 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 7)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4059

Introduced
6/13/23  
To include phosphate and potash on the final list of critical minerals of the Department of the Interior.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB407

Introduced
1/20/23  
Refer
1/20/23  
Protect the UNBORN (Undo the Negligent Biden Orders Right Now) Act or the Protect the UNBORN Act This bill prohibits federal implementation of and funding for specified executive orders that address access to reproductive health care services, including services related to pregnancy or the termination of a pregnancy.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4086

Introduced
6/13/23  
AFFECT Human Rights in Venezuela Act Assuring that the Fact-Finding Examination Continues to Track Human Rights in Venezuela Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4127

Introduced
6/14/23  
Refer
6/14/23  
Fair Access to Agriculture Disaster Programs Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB427

Introduced
1/20/23  
Refer
1/20/23  
Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB431

Introduced
1/20/23  
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4321

Introduced
6/23/23  
No Bailouts for Reparations Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4335

Introduced
6/23/23  
VA Loan Informed Disclosure Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB435

Introduced
1/20/23  
Protecting Life on College Campus Act of 2023 This bill prohibits the award of federal funds to an institution of higher education (IHE) that hosts or is affiliated with a school-based service site that provides abortion drugs or abortions to its students or to employees of the IHE or the site. An IHE that hosts or is affiliated with a site must, in order to remain eligible for federal funds, annually certify that the site does not provide abortion drugs or abortions to students or employees.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4380

Introduced
6/27/23  
Protecting Endowments from Our Adversaries Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4464

Introduced
7/3/23  
Refer
7/3/23  
Refer
8/28/23  
RAISE Act of 2023 Restore Agricultural Investment, Stability, and Expansion Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB448

Introduced
1/24/23  
Putting Investors First Act of 2023 This bill requires a proxy advisory firm to register with the Securities and Exchange Commission and prohibits an unregistered proxy advisory firm from using interstate commerce to provide proxy-voting advice, research, analysis, or recommendations to any client. With respect to these firms, the bill (1) establishes procedures for both registration and termination of registration; (2) requires each firm to employ an ombudsman, designate a compliance officer, and publicly disclose conflicts of interest; (3) allows issuers to assess and comment on proxy voting recommendations; and (4) prohibits unfair, coercive, or abusive practices. The bill establishes a private right of action against a proxy advisory firm that endorses an approved proposal that is not supported by the issuer and is found to be illegal.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4496

Introduced
7/6/23  
American Confidence in Elections: District of Columbia Voter List Maintenance Act

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB416

Introduced
1/20/23  
Refer
1/20/23  
Prohibiting Abortion Industry's Lucrative Loopholes Act This bill expands the prohibition on the sale or purchase of human fetal tissue in interstate commerce to include any payments associated with the transportation, implantation, processing, preservation, quality control, or storage of such tissue.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4162

Introduced
6/15/23  
Refer
6/15/23  
Land Grant Research Prioritization Act of 2023